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Abstract. The next great leap toward improving treatment of cancer with radia-
tion will require the combined use of online adaptive and magnetic resonance 
guided radiation therapy techniques with automatic X-ray beam orientation se-
lection. Unfortunately, by uniting these advancements, we are met with a sub-
stantial expansion in the required dose information and consequential increase to 
the overall computational time imposed during radiation treatment planning, 
which cannot be handled by existing techniques for accelerating Monte Carlo 
dose calculation. We propose a deep convolutional neural network approach that 
unlocks new levels of acceleration and accuracy with regards to post-processed 
Monte Carlo dose results by relying on data-driven learned representations of 
low-level beamlet dose distributions instead of more limited filter-based de-
noising techniques that only utilize the information in a single dose input. Our 
method uses parallel UNET branches acting on three input channels before mix-
ing latent understanding to produce noise-free dose predictions. Our model 
achieves a normalized mean absolute error of only 0.106% compared with the 
ground truth dose contrasting the 25.7% error of the under sampled MC dose fed 
into the network at prediction time. Our model’s per-beamlet prediction time is 
~220ms, including Monte Carlo simulation and network prediction, with sub-
stantial additional acceleration expected from batched processing and combina-
tion with existing Monte Carlo acceleration techniques. Our method shows prom-
ise toward enabling clinical practice of advanced treatment technologies. 
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1 Introduction 
Magnetic resonance guided radiotherapy (MRgRT) is an innovation that asserts domi-
nance over traditional CT-guided radiotherapy with respect to the offered soft tissue 
contrast and imaging flexibility. Such innovations in the pre-treatment imaging and the 
online image-guided contexts have enabled enhanced precision in the treatment of in-
conspicuous and moving lesions. The difficulty of widespread adoption of MRgRT is 
in part due to the complicating behavior of charged particles (electrons) in the presence 
of a moderate to strong magnetic field. The result is a non-negligible perturbation to 
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the more typical dose distributions observed without a strong magnetic field. Great ef-
fort has been invested in acceleration of deterministic dose calculation, including the 
works of Chen [1], Neylon [2] and most recently Neph [3] which emphasize efficient 
GPU implementation. However, the effects of a strong magnetic field fundamentally 
invalidate the assumptions made by these heavily relied upon deterministic dose calcu-
lation algorithms, leaving us instead with highly the accurate and flexible, but compa-
rably less efficient Monte Carlo (MC) dose simulation technique. 
The intersection of MRgRT with other advanced clinical techniques presents a seri-
ous challenge with respect to the capabilities of existing MC dose calculation tools. 
Online adaptive radiotherapy (OART) deviates from the clinical standard by both re-
imaging and re-optimizing RT treatment plans prior to each daily radiation delivery. 
The outcome of OART is increased delivery precision and improved patient outcome 
but is commonly rendered computationally intractable given the insufficient speed of 
both the dose calculation and plan optimization stages. Additionally, the innovation of 
beam orientation optimization (BOO) increases plan quality while simplifying the plan-
ning effort. However, BOO imparts a substantial requirement on the compulsory dose 
data that is calculated prior to the start of planning. Current clinical practice with human 
pre-selection of around 10 static beams necessitates calculation of planning dose dis-
tributions for a few thousand individual beamlets. By comparison, joint optimization of 
beam orientations and their fluence maps performed by 4pi treatment planning, consid-
ers 1162 candidate beam orientations and requires calculation of dose for hundreds of 
thousands of beamlets consequently. 
It is well understood that each of these techniques offer significant and complemen-
tary improvements to the treatment planning process and quality of patient care. How-
ever, the convergence of their practice imposes formidable challenges on the dose cal-
culation component of the planning process; namely that we must simultaneously pivot 
to using more accurate methods, which can handle EREs, while greatly increasing the 
efficiency to handle significant increases to the amount of prerequisite data. In sum-
mary, we must find a way to get the accuracy benefits of MC dose simulation while 
accelerating its computation time beyond that which is possible using any existing MC 
acceleration techniques.  
Previous work on accelerating MC simulation has investigated the use of denoising 
algorithms applied to under sampled (noisy) MC dose. Deasy [4] used a wavelet coef-
ficient thresholding approach to denoising on a slice-by-slice basis. Kawrakow [5] pre-
sents a 3D implementation of locally adaptive Savitzky-Golay filtering that selects the 
anisotropic filter window size by means of a locally supported chi-square test, limiting 
the effect of systematic bias. Fippel [6] proposed an optimization approach including 
both dose fidelity and smoothness regularization terms. Miao [7] investigated the use 
of an adaptive denoising approach modeling the dose in terms of heat transport and 
used anisotropic diffusion to achieve smoothed distributions. El Naqa [8] used a hybrid 
median filtering approach which adapts the filter to the local content of the dose distri-
bution to more effectively tradeoff the benefits of mean- and median-based denoising.  
This existing work places an emphasis on only moderately under sampled dose sug-
gesting their incapacity to robustly and accurately denoise dose with anything beyond 
this modest level of noise or in heterogeneous geometries. El Naqa [9] judges that 
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“uncertainties of greater than 5% are probably too large” for producing clinically usable 
treatment plans, and that “maximum error of denoised distributions can still be large 
for raw MC uncertainties of 3%”, indicating observed errors up to 15% in these cases.  
Our contributions focus on meeting this need. We harness a successful Deep Learn-
ing model architecture, UNET [10], to perform concurrent denoising and prediction of 
noise-free MR-guided beamlet dose from an extremely noisy (and cheap to simulate) 
version of the MC beamlet dose for the given geometry. Additionally, we show that our 
model performs well in previously unseen patient geometries for a given anatomical 
region such as the head and neck, supporting our expectation of its generalizability for 
clinical use. We further note that while our model contributes a significant level of 
acceleration to the task of very-large-scale (VLS) dose calculation, it remains fully 
compatible with existing MC acceleration techniques such as GPU-based simulation 
and variance reduction, reinforcing its promise for clinical application. 
2 Methods 
We present a novel technique for accelerated calculation of X-ray beamlet dose from 
highly under sampled (noisy) Monte Carlo simulation. Our model incorporates the 
widely successful U-NET CNN architecture to learn the actual dose distribution of an 
X-ray beamlet, including perturbations resulting from EREs in the presence of an MR-
induced magnetic field.  
Our model is composed of three independent UNET branches, each with 4 hierar-
chical levels, that learn a latent representation of each of 3 input channels: under sam-
pled dose, MC X-ray fluence, and CT geometry. Channel-specific latent representations 
are mixed in a series of fully convolutional layers which preserve the original data di-
mensionality and produce a prediction of the residual between the input (noisy) and 
ground-truth dose. Adding the residual and input dose gives the predicted noise-free 
dose. A summary of the network architecture is shown in figure 1. 
 
Fig. 1. Monte Carlo dose prediction network architecture. Parallel UNET branches process each 
input channel independently. Concatenation and mixing of latent representations produces 
predicted residual dose. Residual and under sampled doses are summed, giving prediction of fully 
sampled dose. 
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2.1 Monte Carlo Dose Simulation 
A general purpose, CPU-based Monte Carlo particle simulation toolkit, Geant4 v10.4 
[11-12], was used obtain the under sampled and fully sampled beamlet dose distribu-
tions as well as the X-ray fluence for each beamlet configuration. A single instance of 
the fully sampled dose was simulated by tracking 18 million X-rays from a point source 
100cm away from the beamlet’s isocenter in a uniformly diverging square field. Ten 
under sampled doses were additionally simulated by instead tracking 500 X-rays each 
in the same manner. Each beamlet was modeled with an identical histogram-based en-
ergy distribution matching that of a clinical 6MV Bremsstrahlung spectrum. To under-
stand the applicability of our approach to MRgRT, we configured a static 1.5T magnetic 
field, oriented in parallel to the rotation axis of the X-ray source around the treatment 
isocenter; this geometry matches that of existing MRgRT treatment devices such as the 
Elekta Unity©. 
 To standardize the amount of noise present in the under sampled MC dose distribu-
tions, we incrementally simulated beamlet dose for 50 randomly selected beamlets in 
the testing dataset, monitoring the normalized mean absolute error (NMAE) compared 
with the fully sampled dose until it reached a threshold of 25%. For the fully sampled 
dose, we selected an average statistical uncertainty during MC simulation of less than 
0.1% as the threshold. To maintain these average qualities of dose, the under sampled 
inputs and fully sampled ground truths were simulated using 500 and 18 million X-rays 
as described earlier in this section. 
2.2 Dataset Construction 
Beamlets configurations consisted of beam azimuth (gantry angle), isocenter coor-
dinates, and beamlet position within the beam. The parameters of the beamlet configu-
ration were selected randomly to ensure diversity in both the training and testing da-
tasets. Ten head and neck (H&N) CT volumes were retrospectively collected from 
UCLA’s database of radiation treatments and resampled to have an isotropic voxel size 
of 2.5mm3. Six of the patients were reserved for training and the remaining four for 
unbiased testing of the trained model. We are careful to test on patients that are previ-
ously unseen during the training process so an unbiased evaluation of the model gener-
alizability to new patients can be reported. For each training and testing patient, an 
average of 865 and 415 beamlet configurations were randomly sampled, respectively.  
A single data example was created by pairing each three-channel input with the fully 
sampled dose for a specific beamlet configuration. To augment the dataset with extra 
data examples, rather than randomly generate additional beamlet configurations and 
perform additional, and expensive, MC simulation of the fully sampled (ground-truth) 
dose, we recognized that each under sampled simulation of dose is an independent and 
identically distributed (IID) stochastic observation of the fully sampled dose. This al-
lowed us to pair a single fully sampled dose with multiple (currently 10) independent 
under sampled inputs. This augmentation technique is like the addition of zero-mean 
gaussian noise used more commonly in natural image domains, except that we can 
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sample directly from the true noise model by use of MC simulation. After augmenta-
tion, our training and testing datasets contained 155,940 and 49,770 examples, respec-
tively. 
Our model was trained for 150 epochs (~183,000 iterations) in a data-parallel man-
ner across four NVIDIA GTX Titan X graphics processing units (GPUs). Training time 
was approximately 18 hours, though the greatest reduction to the loss function was seen 
after just a few hours. Batch normalization and ReLU operations were used between 
each convolutional layer. 
2.3 Experiment Design 
To assess the accuracy of the predicted beamlet dose results, we computed the NMAE 
across every voxel of every beamlet in the testing dataset. To provide physical meaning 
to this metric, each voxel of the predicted beamlet dose was normalized to the corre-
sponding beamlet-maximum dose, obtained from the fully sampled MC dose volume. 
We also computed spatial gamma index maps, which indicate the dosimetric accuracy 
of voxels by combining the dose difference and distance-to-agreement metrics, for each 
of a pre-determined set of gamma criteria. Readers are referred to [13] for a complete 
description of the gamma index. Voxels with a gamma index of less than or equal to 
1.0, are regarded as passing the gamma test, while those with indices in excess of 1.0 
are failing, which generally indicate regions of degraded dosimetric accuracy. Our re-
sults show passing voxels in blue and failing voxels in red, with white indicating the 
division between the two classifications. Gamma maps are provided for the 
0.2%/0.2mm, 0.5%/0.5mm, and 1%/1mm gamma criteria. In our reporting of the re-
sults, the NMAE was masked to reduce the bias of less-important voxels with very-low 
dose. Our masking operation excludes those voxels having both ground truth and pre-
dicted normalized dose under 10%, which ensures that both the actual dose and any 
possible false predictions of dose are low enough to be ignored in most cases. 
3 Results 
In our experiment, where the accuracy of the under sampled MC dose and the deep 
model predicted dose were compared with respect to the ground truth, a NMAE of 
25.7% before prediction and 0.106% after were observed. Prediction time for a single 
beamlet was approximately 220ms, including both the MC simulation and network pre-
diction steps, while the time to produce a single fully sampled beamlet dose was ap-
proximately 380 seconds on average. Figure 2 shows the under sampled (input), net-
work predicted, and fully sampled (ground truth) dose for a single beamlet passing 
through a large air cavity within the patient’s mouth, where EREs are expected and 
observed. Figure 3 additionally shows the gamma index maps for the beamlet shown in 
figure 2. Darks blue voxels indicate those that easily pass the gamma test for the im-
posed criteria (index much less than 1.0). Dark red voxels conversely indicate dramatic 
failure by the gamma criteria (index much greater than 1.0. Lighter shades of each color, 
and white indicate voxels that lie near the threshold with index value equal to 1.0. 
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Fig. 2. Comparison of under sampled, predicted, and fully sampled (ground truth) dose for one 
beamlet. Bottom row shows close-up of soft tissue-air interfaces where EREs are visible. 
 
Fig. 3. Gamma maps for one under sampled and predicted beamlet dose distribution compared 
to the ground truth (fully sampled dose). Red voxels indicate large disagreement while white 
and blue indicate passing for the referenced gamma criterion. Close-up views given under each. 
4 Discussion 
We observe from the analysis of dosimetric accuracy between the under sampled dose 
and the deep network prediction that a substantial improvement in the beamlet dose 
accuracy is achieved despite imparting less than 200ms for the additional prediction 
step. Indicated by the reduction of NMAE for the testing dataset, the accuracy improve-
ment between the under sampled dose and the predicted dose is greater than two orders 
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of magnitude. Without a dedicated analysis of the resulting effects on the treatment 
planning process, it is difficult to conclude from this study whether the observed accu-
racy is sufficient for clinical use. However, from the conclusions drawn in [9] we show 
that our dose prediction model outperforms existing denoising methods with NMAE 
below 0.2% (improvement ratio of 242) compared to the best performing method of [4] 
achieving an improvement ratio of only 4.5, corresponding to a NMAE of approxi-
mately 1.21% (MSE improvement ratio of 4.5 for the 6.6% uncertainty input) for the 
H&N evaluation. This improvement is evident despite starting with much noisier dose 
inputs (input NMAE of more than 25% in our case, compared with up to 6.6% MC 
uncertainty selected to evaluate the methods of [4] in [9]).  
Furthermore, investigating the predicted dose distribution in figure 2 and the corre-
sponding gamma index maps in figure 3 clearly show the advantage of our deep learn-
ing-based approach in both the global denoising and the local ERE prediction tasks. For 
example, the under sampled dose in figure 2 displays a dose loop which is commonly 
observed in noisy MR-guide MC results but is not representative of the expectation 
obtained by full sampling to a low uncertainty. For these situations, where local filtering 
approaches tend to fail to distinguish this low probability stochastic event from the true 
beamlet structure, our model can disambiguate the two and harness the information to 
produce a more realistic prediction. Moreover, the qualitative differences in the gamma 
maps of figure 3 clearly demonstrate the global predictive performance of our model, 
where the fraction of red voxels is substantially reduced between the under sampled 
and predicted dose distributions. 
Like the denoising methods presented in [4-8], our model also benefits from batched 
evaluation for both the MC simulation and especially the GPU-based model prediction 
steps. The runtimes reported in section 3 were limited to computation of a single beam-
let dose distribution without including the benefits of batched processing. With even a 
modest availability of GPU hardware and GPU-enabled MC simulation tools, we ex-
pect that parallel processing will greatly improve the average per-beamlet processing 
time well beyond that which is required of online adaptive MRgRT. Further investiga-
tion of the limits of acceleration that can be achieved and the benefits to the actual 
process of treatment plan optimization using predicted beamlet dose distributions are 
planned for future work. 
5 Conclusions 
We have demonstrated the success of our novel deep learning-based approach to beam-
let-scale Monte Carlo dose denoising in terms of the computational time and accuracy 
improvements. Our technique differs from existing attempts at MC dose denoising in 
that it: has been evaluated for use in MRgRT where EREs induce local perturbations to 
the simpler no-magnetic-field X-ray dose distribution, is applicable to substantially 
noisier dose input resulting from fewer MC-simulated particles, and benefits from effi-
cient deep CNN prediction while maintaining compatibility with existing MC acceler-
ation techniques. By testing our model performance with patient geometries that were 
not used during model training, our method shows generalizability to new patients, and 
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normalized mean absolute beamlet dose errors of 0.106% on average, compared with 
the 25.7% error observed by directly using the under sampled dose. This performance 
is demonstrated while reducing the dose calculation time by over two orders of magni-
tude compared with fully sampled MC beamlet dose. Our method shows promise in 
enabling clinical use of adaptive online MRgRT for automatically planned treatments. 
References 
1. Chen, Q., Chen, M., & Lu, W. (2011). Ultrafast convolution/superposition using tabulated 
and exponential kernels on GPU. Medical Physics, 38(3), 1150–1161. 
https://doi.org/10.1118/1.3551996 
2. Neylon, J., Sheng, K., Yu, V., Chen, Q., Low, D. A., Kupelian, P., & Santhanam, A. (2014). 
A nonvoxel-based dose convolution/superposition algorithm optimized for scalable GPU 
architectures. Medical Physics, 41(10), 101711. https://doi.org/10.1118/1.4895822 
3. Neph, R., Ouyang, C., Neylon, J., Yang, Y. M., & Sheng, K. (2019). Parallel Beamlet Dose 
Calculation via Beamlet Contexts in a Distributed Multi‐GPU Framework. Medical Physics, 
mp.13651. https://doi.org/10.1002/mp.13651 
4. Deasy, J. O., Wickerhauser, M. V., & Picard, M. (2002). Accelerating Monte Carlo simula-
tions of radiation therapy dose distributions using wavelet threshold de-noising. Medical 
Physics, 29(10), 2366–2373. https://doi.org/10.1118/1.1508112 
5. Kawrakow, I. (2002). On the de-noising of Monte Carlo calculated dose distributions. Phys-
ics in Medicine and Biology, 47(17), 304. https://doi.org/10.1088/0031-9155/47/17/304 
6. Fippel, M., & Nüsslin, F. (2003). Smoothing Monte Carlo calculated dose distributions by 
iterative reduction of noise. Physics in Medicine and Biology, 48(10), 1289–1304. 
https://doi.org/10.1088/0031-9155/48/10/304 
7. Miao, B., Jeraj, R., Bao, S., & Mackie, T. R. (2003). Adaptive anisotropic diffusion filtering 
of Monte Carlo dose distributions. Physics in Medicine and Biology, 48(17), 2767–2781. 
https://doi.org/10.1088/0031-9155/48/17/303 
8. Naqa, I. El, Deasy, J. O., & Vicic, M. (2003). Locally adaptive denoising of Monte Carlo 
dose distributions via hybrid median filtering. IEEE Nuclear Science Symposium, 2703–
2706. https://doi.org/0-7803-8257-9/04 
9. El Naqa, I., Kawrakow, I., Fippel, M., Siebers, J. V., Lindsay, P. E., Wickerhauser, M. V., 
… Deasy, J. O. (2005). A comparison of Monte Carlo dose calculation denoising techniques. 
Physics in Medicine and Biology, 50(5), 909–922. https://doi.org/10.1088/0031-
9155/50/5/014 
10. Ronneberger, O., Fischer, P., & Brox, T. (2015). U-Net: Convolutional Networks for Bio-
medical Image Segmentation. 1–8. https://doi.org/10.1007/978-3-319-24574-4_28 
11. Agostinelli, S., Allison, J., Amako, K., Apostolakis, J., Araujo, H., Arce, P., … Zschiesche, 
D. (2003). Geant4—a simulation toolkit. Nuclear Instruments and Methods in Physics Re-
search Section A: Accelerators, Spectrometers, Detectors and Associated Equipment, 
506(3), 250–303. https://doi.org/10.1016/S0168-9002(03)01368-8 
12. Allison, J., Amako, K., Apostolakis, J., Arce, P., Asai, M., Aso, T., … Yoshida, H. (2016). 
Recent developments in Geant4. Nuclear Instruments and Methods in Physics Research Sec-
tion A: Accelerators, Spectrometers, Detectors and Associated Equipment, 835, 186–225. 
https://doi.org/10.1016/j.nima.2016.06.125 
13. Low, D. A., Harms, W. B., Mutic, S., & Purdy, J. A. (1998). A technique for the quantitative 
evaluation of dose distributions. Medical Physics, 25(5), 656–661. 
https://doi.org/10.1118/1.598248 
